{"disease":{"id":"hypertensive-disorder","name":"Hypertensive disorder","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":116,"pipeline_drug_count":0,"trial_count":2},"drugs":{"marketed":[{"drug_id":"valsartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diovan","generic_name":"VALSARTAN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":"447","mechanism":"Diovan works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"nab-paclitaxel","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"nab-paclitaxel","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor","quality_score":57,"revenue":"368","mechanism":""},{"drug_id":"paclitaxel","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"paclitaxel","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor [EPC]","quality_score":76,"revenue":"368","mechanism":""},{"drug_id":"nabpaclitaxel","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Taxol","generic_name":"Nabpaclitaxel","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Tubulin beta-3 chain","drug_class":"Microtubule Inhibitor","quality_score":null,"revenue":"368","mechanism":"Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division."},{"drug_id":"spironolacton","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Spironolacton","company_name":"ACS Biomarker","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"temocapril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TEMOCAPRIL","company_name":"","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"temocapril","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"tasosartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Verdia","generic_name":"TASOSARTAN","company_name":"","drug_phase":"phase_2","molecular_target":"Type-1 angiotensin II receptor","drug_class":"tasosartan","quality_score":10,"revenue":null,"mechanism":"Verdia works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"guanethidine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ismelin","generic_name":"GUANETHIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"guanethidine","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"s-nitrendipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(-)-Nitrendipine","generic_name":"(S)-nitrendipine","company_name":"","drug_phase":"unknown","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1D","drug_class":"(S)-nitrendipine","quality_score":null,"revenue":null,"mechanism":"Nitrendipine works by blocking calcium channels in the heart and blood vessels, which helps to relax and widen blood vessels, reducing blood pressure."},{"drug_id":"chlorothiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diuril","generic_name":"CHLOROTHIAZIDE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"irbesartan-hydrochloride","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN HYDROCHLORIDE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Avapro works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"perindopril-arginine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aceon","generic_name":"PERINDOPRIL ARGININE","company_name":"Symplmed Pharms Llc","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"clonidine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Catapres-Tts-1","generic_name":"CLONIDINE","company_name":"Lavipharm","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"Central alpha-2 Adrenergic Agonist","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"nebivolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bystolic","generic_name":"nebivolol","company_name":"Allergan","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1A, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"amiloride","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Midamor","generic_name":"AMILORIDE","company_name":"Padagis Us","drug_phase":"marketed","molecular_target":"Amiloride-sensitive sodium channel, ENaC","drug_class":"Potassium-sparing Diuretic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"enalapril-maleate","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"acebutolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sectral","generic_name":"ACEBUTOLOL","company_name":"Promius Pharma","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"eprosartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Teveten","generic_name":"EPROSARTAN","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"zofenopril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sq. 26,991","generic_name":"ZOFENOPRIL","company_name":"","drug_phase":"phase_2","molecular_target":"Angiotensin-converting enzyme","drug_class":"zofenopril","quality_score":null,"revenue":null,"mechanism":"Zofenopril works by blocking the action of angiotensin-converting enzyme, a key component in the renin-angiotensin-aldosterone system that regulates blood pressure."},{"drug_id":"losartan-potassium","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"LOSARTAN POTASSIUM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":69,"revenue":null,"mechanism":"Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure."},{"drug_id":"captopril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Capozide 25/15","generic_name":"CAPTOPRIL","company_name":"Aarxion Anda Hlding","drug_phase":"marketed","molecular_target":"Renin","drug_class":"Thiazide Diuretic [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"quinapril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accupril","generic_name":"QUINAPRIL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"doxazosin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardura","generic_name":"DOXAZOSIN","company_name":"Viatris","drug_phase":"marketed","molecular_target":"Alpha-1B adrenergic receptor","drug_class":"alpha-Adrenergic Blocker","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"aliskiren","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tekturna","generic_name":"ALISKIREN","company_name":"Lxo Ireland","drug_phase":"marketed","molecular_target":"Renin","drug_class":"Renin Inhibitor","quality_score":66,"revenue":null,"mechanism":"Tekturna works by blocking the renin enzyme, which is involved in the production of angiotensin II, a potent vasoconstrictor."},{"drug_id":"xipamide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diurex","generic_name":"XIPAMIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"xipamide","quality_score":null,"revenue":null,"mechanism":"Diurex works by inhibiting the sodium-chloride cotransporter in the kidneys."},{"drug_id":"aranidipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sapresta","generic_name":"ARANIDIPINE","company_name":"","drug_phase":"phase_2","molecular_target":"Voltage-gated L-type calcium channel","drug_class":"aranidipine","quality_score":null,"revenue":null,"mechanism":"Aranidipine works by blocking the L-type calcium channel, which reduces the amount of calcium entering the heart and blood vessels, leading to lower blood pressure."},{"drug_id":"azilsartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"AZILSARTAN","company_name":"","drug_phase":"discontinued","molecular_target":"Type-1 angiotensin II receptor, Type-1 angiotensin II receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"12.1 Mechanism of Action The active ingredients of Edarbyclor target two separate mechanisms involved in blood pressure regulation."},{"drug_id":"cilazapril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vascace","generic_name":"CILAZAPRIL","company_name":"","drug_phase":"phase_2","molecular_target":"Angiotensin-converting enzyme","drug_class":"cilazapril","quality_score":0,"revenue":null,"mechanism":"Cilazapril blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"bendazol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dibazol","generic_name":"BENDAZOL","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"bendazol","quality_score":null,"revenue":null,"mechanism":"Dibazol works by interacting with a specific biological target to produce a therapeutic effect."},{"drug_id":"eplerenone","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inspra","generic_name":"EPLERENONE","company_name":"Upjohn","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Aldosterone Antagonist [EPC]","quality_score":60,"revenue":null,"mechanism":"Inspra works by blocking the action of aldosterone, a hormone that can cause the body to retain too much salt and water."},{"drug_id":"clevidipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleviprex","generic_name":"CLEVIDIPINE","company_name":"Chiesi","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":58,"revenue":null,"mechanism":"Cleviprex works by blocking calcium channels in blood vessel walls, causing them to relax and lower blood pressure."},{"drug_id":"nisoldipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sular","generic_name":"NISOLDIPINE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":75,"revenue":null,"mechanism":"Sular works by blocking calcium channels in blood vessel walls, which relaxes the blood vessels and lowers blood pressure."},{"drug_id":"candesartan-cilexetil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atacand","generic_name":"CANDESARTAN CILEXETIL","company_name":"ANI Pharmaceuticals","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":10,"revenue":null,"mechanism":"Atacand blocks the action of angiotensin II, a hormone that constricts blood vessels, to lower blood pressure and improve heart function."},{"drug_id":"nifedipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procardia","generic_name":"NIFEDIPINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"bendroflumethiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Corzide","generic_name":"BENDROFLUMETHIAZIDE","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"spirapril-hydrochloride","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Renormax","generic_name":"SPIRAPRIL HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"spirapril","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"verapamil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isoptin","generic_name":"VERAPAMIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Calcium Channel Blocker","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"metoprolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopressor","generic_name":"metoprolol","company_name":"Generic (originally Ciba-Geigy/Novartis)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, 5-hydroxytryptamine receptor 1A","drug_class":"Beta-1 selective blocker","quality_score":58,"revenue":null,"mechanism":"Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand."},{"drug_id":"frusemide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Frusemide","company_name":"Melbourne Health","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lisinopril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zestril","generic_name":"lisinopril","company_name":"Generic (originally Merck/AstraZeneca)","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme, Angiotensin-converting enzyme","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Inhibits angiotensin-converting enzyme (ACE), preventing conversion of angiotensin I to angiotensin II, lowering blood pressure and reducing cardiac workload."},{"drug_id":"clonidin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clonidin","company_name":"Medical University of Vienna","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 1, Solute carrier family 22 member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"torasemide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Torasemide","company_name":"Medical University of Warsaw","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"telmisartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micardis","generic_name":"TELMISARTAN","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Type-2 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Micardis works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"alis","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALIS","company_name":"Lxo Ireland","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, Renin","drug_class":"","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"methylclothiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Enduron","generic_name":"methylclothiazide","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lercanidipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zanidip","generic_name":"LERCANIDIPINE","company_name":"","drug_phase":"phase_3","molecular_target":"Voltage-gated L-type calcium channel","drug_class":"lercanidipine","quality_score":null,"revenue":null,"mechanism":"Zanidip works by blocking calcium channels in blood vessel walls, causing them to relax and widen."},{"drug_id":"epitizide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epitizid","generic_name":"epitizide","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"epitizide","quality_score":null,"revenue":null,"mechanism":"Epitizide is thought to work by interacting with a specific target to produce a therapeutic effect."},{"drug_id":"mibefradil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Posicor","generic_name":"MIBEFRADIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1I","drug_class":"mibefradil","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ketanserin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ketensin","generic_name":"KETANSERIN","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"ketanserin","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"azelnidipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calblock","generic_name":"AZELNIDIPINE","company_name":"","drug_phase":"phase_3","molecular_target":"Voltage-gated L-type calcium channel","drug_class":"azelnidipine","quality_score":null,"revenue":null,"mechanism":"Calblock works by blocking calcium channels in blood vessel walls, which helps to relax the vessels and lower blood pressure."},{"drug_id":"metipamide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hypotylin","generic_name":"metipamide","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"metipamide","quality_score":null,"revenue":null,"mechanism":"Metipamide works by inhibiting gastric acid secretion, reducing the amount of acid produced in the stomach."},{"drug_id":"altizide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Altizid","generic_name":"altizide","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"altizide","quality_score":null,"revenue":null,"mechanism":"Altizide works by inhibiting the reabsorption of sodium and chloride in the kidneys."},{"drug_id":"piretanide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arelix","generic_name":"PIRETANIDE","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"piretanide","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"flumethiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flumetiazid","generic_name":"FLUMETHIAZIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"flumethiazide","quality_score":null,"revenue":null,"mechanism":"Flumethiazide works by blocking the reabsorption of sodium and chloride ions in the kidneys, leading to increased urine production and reduced blood pressure."},{"drug_id":"benzylhydrochlorothiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Behyd","generic_name":"benzylhydrochlorothiazide","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Behyd works by blocking sodium reabsorption in the kidneys, which increases urine production and reduces blood pressure."},{"drug_id":"reserpiline","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reserpilin","generic_name":"reserpiline","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Reserpine works by depleting catecholamines and serotonin in the brain, leading to a decrease in sympathetic nervous system activity."},{"drug_id":"efonidipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zeria","generic_name":"EFONIDIPINE","company_name":"","drug_phase":"phase_2","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1H","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Zeria works by blocking the T-type calcium channel, which helps to relax blood vessels and lower blood pressure."},{"drug_id":"chlortalidone","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Combipres","generic_name":"Chlortalidone","company_name":"University Hospital Birmingham","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 7","drug_class":"Thiazide-like Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"celiprolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selectol","generic_name":"CELIPROLOL","company_name":"","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"celiprolol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"azilsartan-medoxomil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Edarbi","generic_name":"AZILSARTAN MEDOXOMIL","company_name":"Arbor Pharms Ireland","drug_phase":"marketed","molecular_target":"AT1 receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":59,"revenue":null,"mechanism":"Azilsartan blocks angiotensin II's vasoconstrictor and aldosterone-secreting effects by selectively binding to the AT1 receptor."},{"drug_id":"diltiazem","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardizem","generic_name":"diltiazem","company_name":"Generic (originally Tanabe Seiyaku)","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel gamma-1 subunit, Multidrug resistance protein 1, Solute carrier family 22 member 1","drug_class":"Calcium channel blocker (non-dihydropyridine, benzothiazepine)","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"enalapril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"enalapril","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme, Angiotensin-converting enzyme","drug_class":"ACE inhibitor","quality_score":60,"revenue":null,"mechanism":"ACE inhibitor prodrug that is converted to enalaprilat, blocking angiotensin-converting enzyme to lower blood pressure."},{"drug_id":"methyldopate","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldomet","generic_name":"METHYLDOPATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Adrenergic receptor alpha-2","drug_class":"","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"felodipin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"felodipin","company_name":"Sahlgrenska University Hospital","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Adenosine receptor A3, Cytochrome P450 2C9","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"hydrochlorothiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Microzide","generic_name":"hydrochlorothiazide","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"ACE","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure."},{"drug_id":"tienilic-acid","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selacryn","generic_name":"tienilic acid","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"tienilic acid","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"spironolactone","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"spironolactone","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"Aldosterone Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure."},{"drug_id":"losartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"losartan","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"AT1 receptor","drug_class":"ARB (Angiotensin II receptor blocker)","quality_score":65,"revenue":null,"mechanism":"Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor."},{"drug_id":"pindolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Visken","generic_name":"PINDOLOL","company_name":"","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"propranolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inderal","generic_name":"propranolol","company_name":"Generic (originally ICI/AstraZeneca)","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, 5-hydroxytryptamine receptor 6, Cytochrome P450 1A2","drug_class":"Non-selective beta-blocker","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"endralazine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miretilan","generic_name":"ENDRALAZINE","company_name":"","drug_phase":"phase_2","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"endralazine","quality_score":null,"revenue":null,"mechanism":"Miretilan works by blocking calcium channels in blood vessels, which helps to lower blood pressure."},{"drug_id":"olmesartan-medoxomil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benicar","generic_name":"OLMESARTAN MEDOXOMIL","company_name":"Cosette","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Thiazide Diuretic [EPC]","quality_score":70,"revenue":null,"mechanism":"Benicar works by blocking the action of angiotensin II, a hormone that constricts blood vessels, to lower blood pressure."},{"drug_id":"prazosin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Minipress","generic_name":"PRAZOSIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"alpha-Adrenergic Blocker","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"procardia-xl","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procardia","generic_name":"Nifedipine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"benazepril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotensin","generic_name":"BENAZEPRIL","company_name":"Validus Pharms","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"guanfacine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tenex","generic_name":"GUANFACINE","company_name":"Promius Pharma","drug_phase":"marketed","molecular_target":"Nischarin","drug_class":"Central alpha-2 Adrenergic Agonist","quality_score":65,"revenue":null,"mechanism":"Tenex works by stimulating alpha-2 adrenergic receptors in the brain, which helps to reduce the activity of certain nerve cells."},{"drug_id":"carvedilol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coreg","generic_name":"CARVEDILOL","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"alpha-Adrenergic Blocker [EPC]","quality_score":70,"revenue":null,"mechanism":"Coreg works by blocking the effects of the hormone epinephrine on the heart, reducing its workload and improving its function."},{"drug_id":"terazosin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hytrin","generic_name":"TERAZOSIN","company_name":"","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Blocker","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fosinopril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monopril","generic_name":"FOSINOPRIL","company_name":"","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":64,"revenue":null,"mechanism":"Monopril works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"isradipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dynacirc","generic_name":"ISRADIPINE","company_name":"Smithkline Beecham","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1D","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"nadolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Corgard","generic_name":"NADOLOL","company_name":"Uswm","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Blocker [EPC]","quality_score":54,"revenue":null,"mechanism":""},{"drug_id":"bisoprolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zebeta","generic_name":"BISOPROLOL","company_name":"Teva","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"isotretinoin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accutane","generic_name":"ISOTRETINOIN","company_name":"","drug_phase":"marketed","molecular_target":"Retinoic acid receptor alpha","drug_class":"Retinoid [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"carteolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ocupress","generic_name":"CARTEOLOL","company_name":"","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"enalaprilat","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRILAT","company_name":"Biovail Labs Intl","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"enalaprilat","quality_score":75,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"guanadrel","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hylorel","generic_name":"GUANADREL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"guanadrel","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"nitroprusside","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sodium Nitroprusside","generic_name":"NITROPRUSSIDE","company_name":"Roche","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1","drug_class":"Vasodilator","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"delapril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alindapril","generic_name":"DELAPRIL","company_name":"","drug_phase":"phase_3","molecular_target":"Angiotensin-converting enzyme","drug_class":"delapril","quality_score":null,"revenue":null,"mechanism":"Delapril works by blocking the action of angiotensin-converting enzyme, a protein that constricts blood vessels."},{"drug_id":"methyldopa","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldomet","generic_name":"METHYLDOPA","company_name":"","drug_phase":"marketed","molecular_target":"Lysine-specific demethylase 4E","drug_class":"methyldopa","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"nicardipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardene","generic_name":"NICARDIPINE","company_name":"Hikma Intl Pharms","drug_phase":"marketed","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1H","drug_class":"Dihydropyridine Calcium Channel Blocker","quality_score":80,"revenue":null,"mechanism":"Cardene works by blocking calcium channels in the heart and blood vessels, which helps to relax and widen blood vessels, reducing blood pressure and heart workload."},{"drug_id":"betaxolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betoptic","generic_name":"BETAXOLOL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker","quality_score":10,"revenue":null,"mechanism":"Betaxolol works by blocking the beta-1 adrenergic receptor in the heart and eyes, reducing heart rate and pressure, and decreasing intraocular pressure."},{"drug_id":"irbesartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"metolazone","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zaroxolyn","generic_name":"METOLAZONE","company_name":"I3 Pharms","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 7","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"indapamide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lozol","generic_name":"INDAPAMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 7","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"furosemide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lasix","generic_name":"furosemide","company_name":"Generic (originally Hoechst AG)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35","drug_class":"Loop Diuretic [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"atenolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tenoretic 100","generic_name":"ATENOLOL","company_name":"Twi Pharms","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"beta-Adrenergic Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"labetalol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Normodyne","generic_name":"LABETALOL","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"beta-Adrenergic Blocker","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"felodipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plendil","generic_name":"FELODIPINE","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1H","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":75,"revenue":null,"mechanism":"Plendil works by blocking calcium channels in blood vessel walls, causing them to relax and widen, which lowers blood pressure."},{"drug_id":"ramipril","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Altace","generic_name":"RAMIPRIL","company_name":"King Pfizer","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor [EPC]","quality_score":80,"revenue":null,"mechanism":"Altace works by blocking the action of angiotensin-converting enzyme, a key player in the renin-angiotensin-aldosterone system that regulates blood pressure."},{"drug_id":"hydroflumethiazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Saluron","generic_name":"HYDROFLUMETHIAZIDE","company_name":"Shire Llc","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"amlodipine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norvasc","generic_name":"amlodipine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"Calcium channel blocker (dihydropyridine)","quality_score":55,"revenue":null,"mechanism":"Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand."},{"drug_id":"terazosine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Terazosine","company_name":"University of Iowa","drug_phase":"phase_2","molecular_target":"Ribosyldihydronicotinamide dehydrogenase [quinone], Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bendrofluazide","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bendrofluazide","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Calcium-activated potassium channel subunit alpha-1, Carbonic anhydrase 1, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"abraxane","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Abraxane","company_name":"The First Affiliated Hospital with Nanjing Medical University","drug_phase":"marketed","molecular_target":"Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"olmetec","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Olmetec","company_name":"Daewoong Pharmaceutical Co. LTD.","drug_phase":"phase_1","molecular_target":"Type-1 angiotensin II receptor, Type-1 angiotensin II receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pritor","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pritor","company_name":"DongKoo Bio & Pharma","drug_phase":"phase_1","molecular_target":"ATP-binding cassette sub-family G member 2, Multidrug and toxin extrusion protein 1, Type-2 angiotensin II receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"amlodipin","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amlodipin","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mavik","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mavik","company_name":"Dr. Reddy's Laboratories Limited","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"spirolactone","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"spirolactone","company_name":"Second Xiangya Hospital of Central South University","drug_phase":"phase_1","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"taxol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Taxol","company_name":"M.D. Anderson Cancer Center","drug_phase":"marketed","molecular_target":"Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zanidip","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zanidip","company_name":"Lee's Pharmaceutical Limited","drug_phase":"marketed","molecular_target":"Voltage-gated L-type calcium channel","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mecamylamine","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inversine","generic_name":"MECAMYLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha3/beta2","drug_class":"Autonomic Ganglionic Blocker","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"minoxidil","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rogaine","generic_name":"minoxidil","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"ATP-sensitive inward rectifier potassium channel 1, Sulfonylurea receptor 2, Kir6.2","drug_class":"Vasodilator (potassium channel opener), Hair growth stimulant","quality_score":null,"revenue":null,"mechanism":"Potassium channel opener that stimulates hair follicles (topical) or causes arteriolar vasodilation (oral) for hair loss and severe hypertension."},{"drug_id":"bupranolol","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupranol","generic_name":"BUPRANOLOL","company_name":"","drug_phase":"phase_2","molecular_target":"Beta-2 adrenergic receptor","drug_class":"bupranolol","quality_score":31,"revenue":null,"mechanism":"Bupranol works by blocking the beta-2 adrenergic receptor, which helps to reduce the pressure in the eye and lower blood pressure."},{"drug_id":"fimasartan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kanarb","generic_name":"FIMASARTAN","company_name":"","drug_phase":"discontinued","molecular_target":"Type-1 angiotensin II receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Kanarb works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"diovan","indication_name":"Hypertensive disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diovan","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Platelet glycoprotein VI, Type-1 angiotensin II receptor, Angiotensin II receptor (AT-1) type-1","drug_class":"","quality_score":23,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":116,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06468202","title":"Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":10742,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT05089175","title":"The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population","phase":"","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Women's Hospital School Of Medicine Zhejiang University","has_results":false},{"nct_id":"NCT07294807","title":"Pregnancy Salt Substitution Trial for Hypertensive Disorders of Pregnancy Prevention (PREG-Salt)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3200,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT06115122","title":"PEPPI Study: Identification of Women at Risk for Placental Dysfunction","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Oulu University Hospital","has_results":false},{"nct_id":"NCT04989634","title":"Effects of Dietary and Weight Management on Pregnancy Outcomes in Mobile Medical Platform","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT03412552","title":"Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia","phase":"","overall_status":"COMPLETED","enrollment_count":1238,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT06053203","title":"Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07243886","title":"Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":864,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07438379","title":"Exploring Reproductive Health Among Women in Somaliland","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":808,"lead_sponsor_name":"University of Hargeisa","has_results":false},{"nct_id":"NCT07448597","title":"Progesterone Preeclampsia","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":642,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT07017920","title":"Vitamin D and Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":594,"lead_sponsor_name":"TriHealth Inc.","has_results":false},{"nct_id":"NCT07263490","title":"PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)","phase":"","overall_status":"RECRUITING","enrollment_count":462,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT05655936","title":"Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":454,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT07337759","title":"Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic Pregnancies","phase":"","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"University of Belgrade","has_results":false},{"nct_id":"NCT06995456","title":"Multivariate Analysis and Prediction of Hypertensive Disorder Complicating Pregnancy and Its Related Mechanism","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"First Affiliated Hospital of Harbin Medical University","has_results":false},{"nct_id":"NCT07204756","title":"HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT07187713","title":"ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ace Cells Lab Limited","has_results":false},{"nct_id":"NCT07405723","title":"Arm Position and Blood Pressure Measurement Accuracy During Pregnancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT04660032","title":"Nudge to Drive Transitions of Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03728790","title":"Remote BP Monitoring in the PP Period","phase":"NA","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT06362356","title":"Microbial Metabolites and Outcomes of Pregnancy Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT05659173","title":"Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Universiti Putra Malaysia","has_results":false},{"nct_id":"NCT05631067","title":"Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07299773","title":"Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07349277","title":"Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ammar Jassim Abed","has_results":false},{"nct_id":"NCT04126629","title":"Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The Cooper Health System","has_results":false},{"nct_id":"NCT07486375","title":"Self-Management App for Blood Pressure and Well-Being in Postpartum Women With Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT06632379","title":"AtorvaStatin Postpartum and Reduction of Cardiovascular risK","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT06069102","title":"Optimal Blood Pressure Treatment Thresholds Postpartum","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Alisse Hauspurg","has_results":false},{"nct_id":"NCT07222852","title":"Cardiovascular Protection After Preeclampsia With Enalapril","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT06281665","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Malamo Countouris","has_results":false},{"nct_id":"NCT05837962","title":"Nursing Intervention for Knowledge and Self-care Behaviors in the Face of Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Universidad de Antioquia","has_results":false},{"nct_id":"NCT03309826","title":"Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Dr John Kimoff","has_results":false},{"nct_id":"NCT05124327","title":"Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT06019715","title":"Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Jackie Dziewior","has_results":false},{"nct_id":"NCT05612984","title":"Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}